According to Nevro 's latest financial reports and stock price the company's current Operating Margin is 1.15%. At the end of 2021 the company had an Operating Margin of -33.81%.
Year | Operating Margin | Change |
---|---|---|
2021 | -33.81% | 48.94% |
2020 | -22.70% | -13.21% |
2019 | -26.16% | 109.16% |
2018 | -12.51% | 15.9% |
2017 | -10.79% | -18.23% |
2016 | -13.20% | -86.14% |
2015 | -95.20% | 2.67% |
2014 | -92.72% | -15.06% |
2013 | -109.16% | 5.36% |
2012 | -103.61% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 14.17% | 1,132.17% | ๐บ๐ธ USA |
Abiomed ABMD | 31.76% | 2,661.74% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | 25.82% | 2,145.22% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | -2.90% | -352.17% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.